Subscribe to RSS
DOI: 10.1055/s-0030-1250100
© Georg Thieme Verlag KG Stuttgart · New York
Resection of Giant Typical Carcinoid Tumor with Cardiopulmonary Bypass Support
Publication History
received April 19, 2010
Publication Date:
25 November 2010 (online)
Abstract
Carcinoids, defined as well-differentiated neuroendocrine tumors, are classified as typical or atypical based on their microscopic pathological features. Typical carcinoids have a favorable prognosis after complete resection, with 10-year survival rates of up to 90 %. We present the surgical strategy used to achieve a left pneumonectomy and the indications for cardiopulmonary bypass (CPB) support in a patient with a huge typical carcinoid tumor.
Key words
Thoracic surgery - lung cancer - carcinoid tumor - cardiopulmonary bypass - lung resection - pneumonectomy
References
- 1 Arrigoni M G, Woolner L B, Bernatz P E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972; 64 413-421
- 2 Travis W D, Rush W, Flieder D B et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998; 22 934-944
- 3 Luckraz H, Amer K, Thomas L, Gibbs A, Butchart E G. Long-term outcome of bronchoscopically resected endobronchial typical carcinoid tumors. J Thorac Cardiovasc Surg. 2006; 132 113-115
- 4 Sheppard B B, Follette M D, Meyers J F. Giant carcinoid tumor of the lung. Ann Thorac Surg. 1997; 63 851-852
- 5 Watanabe Y, Ichihashi T, Iwa T. Median sternotomy as an approach for pulmonary surgery. Thorac Cardiovasc Surg. 1988; 36 227-231
- 6 Wiebe K, Baraki H, Macchiarini P, Haverich A. Extended pulmonary resections of advanced malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2006; 29 571-577
- 7 Cooper J D, Nelems J M, Pearson F G. Extended indications for median sternotomy in patients requiring pulmonary resection. Ann Thoracic Surg. 1978; 26 413-420
- 8 Asaph J W, Handy J R, Grunkemeier G L et al. Median sternotomy versus thoracotomy to resect primary lung cancer: analysis of 815 cases. Ann Thorac Surg. 2000; 70 373-379
Dr. Luca Ampollini
Thoracic Surgery
Department of Surgical Sciences
University Hospital of Parma
Via Gramsci 14
43126 Parma
Italy
Phone: +39 05 21 70 22 90
Fax: +39 05 21 70 35 59
Email: lampollini@ao.pr.it